Literature DB >> 15254776

Early graft hemodynamics in living related liver transplantation evaluated by Doppler ultrasonography.

Shigeo Nakanishi1, Katsuya Shiraki, Kouji Yamamoto, Yukiko Saitou, Shigeru Ohmori, Takeshi Nakano, Shugo Mizuno, Masami Tabata, Kentarou Yamagiwa, Hajime Yokoi, Shuji Isaji, Shinji Uemoto.   

Abstract

The aim of this study was to clarify the perioperative hemodynamics of liver grafts without vascular complications during and early after liver transplantation from living donors. This study was carried out in 4 child recipients (lateral segment left lobe grafts) and 6 adult recipients (right lobe grafts) of liver transplantation from living donors. The hemodynamics of the hepatic artery, portal vein, and hepatic vein of the grafts during and until 7 days after surgery were studied by Doppler ultrasonography. The maximum flow velocity of the hepatic artery, mean portal blood flow velocity, and pulsatility index (PI) of the hepatic artery increased in all 10 grafts with no vascular complication after vascular anastomosis. After surgery, the mean portal blood flow velocity showed a peak 3 days after surgery and reached a nadir 7 days after surgery in both the lateral segment left lobe grafts in children and the right lobe grafts in adults, but it was significantly higher in the right lobe grafts in adults (mean +/- SD 31.0 +/- 6.3 vs. 22.4 +/- 0.9 cm/sec). Also, as the hepatic artery blood flow velocity increased the portal blood flow velocity decreased, the hepatic blood flow during liver regeneration was suggested to be controlled by both the artery and portal vein. The range of PI of the hepatic artery was 0.60-1.86. The mean hepatic venous blood flow was stable throughout the observation period (30.4 +/- 8.8 cm/sec). Although the hepatic venous flow waves changed widely from pulsed waves to a flat flow, its changes did not suggest a vascular complication. Evaluation of changes by Doppler ultrasonography in the hemodynamics of the liver grafts without vascular complications during and early after liver transplantation from living donors is considered to be useful for accurate monitoring of the hemodynamics during liver regeneration and early detection of abnormalities.

Entities:  

Mesh:

Year:  2004        PMID: 15254776

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  4 in total

1.  Stability of cirrhotic systemic hemodynamics ensures sufficient splanchnic blood flow after living-donor liver transplantation in adult recipients with liver cirrhosis.

Authors:  Tomohide Hori; Shintaro Yagi; Taku Iida; Kentaro Taniguchi; Kentaro Yamagiwa; Chiduru Yamamoto; Takashi Hasegawa; Koichiro Yamakado; Takuma Kato; Kanako Saito; Linan Wang; Mie Torii; Yukinobu Hori; Kan Takeda; Kazuo Maruyama; Shinji Uemoto
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

2.  Study of Early Postoperative Doppler Changes Post Living Donor Liver Transplantation and Their Impact on Early Mortality and Small-for-Size Syndrome: A Retrospective Study.

Authors:  Ahmed Salman; Amany Sholkamy; Mohamed Salman; Mahmoud Omar; Amr Saadawy; Ahmed Abdulsamad; Mohamed Tourky; Mohamed D Sarhan; Hossam El-Din Shaaban; Nesrin Abd Allah; Mohamed Shawkat
Journal:  Int J Gen Med       Date:  2021-01-28

3.  Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation.

Authors:  Johannes Dillmann; Felix C Popp; Barbara Fillenberg; Florian Zeman; Elke Eggenhofer; Stefan Farkas; Marcus N Scherer; Michael Koller; Edward K Geissler; Robert Deans; Deborah Ladenheim; Martin Loss; Hans J Schlitt; Marc H Dahlke
Journal:  Trials       Date:  2012-11-15       Impact factor: 2.279

4.  The postoperative hepatic artery resistance index after living donor liver transplantation can predict early allograft dysfunction.

Authors:  Tao Lv; LingXiang Kong; Jiayin Yang; Hong Wu; Tianfu Wen; Li Jiang; Jian Yang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.